Generex Biotechnology
(OTC) GNBT
This security has been delisted. This page is retained for historical reference.
GNBT News
Wall Street's Best Hidden Stocks
Unloved Stocks Ready to Shine
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowGNBT Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
-7%
Net Income Margin
-13%
Return on Equity
2%
Return on Capital
-4%
Return on Assets
-73%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.08M
Operating Income
$17.92M
EBITDA
$26.11M
Operating Cash Flow
$6.12M
Capital Expenditure
$4.62K
Free Cash Flow
$6.13M
Cash & ST Invst.
$15.45K
Total Debt
$11.23M
Generex Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$20.70K
-95.9%
Gross Profit
$45.30K
-111.8%
Gross Margin
-2.19%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
15
N/A
Net Income
$9.22M
+6982.8%
EBITDA
$9.82M
+343.8%
Quarterly Fundamentals
Net Cash
$7.61M
+35.6%
Accounts Receivable
$52.30K
-63.2%
Inventory
$232.12K
-74.5%
Long Term Debt
$654.05K
+16.8%
Short Term Debt
$8.63M
-26.0%
Return on Assets
-73.45%
N/A
Return on Invested Capital
-4.47%
N/A
Free Cash Flow
$576.69K
+164.9%
Operating Cash Flow
$576.69K
+164.9%